wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42344252-49CF510A-61F4-440C-9E04-5E68C9D89FD6
Q42344252-49CF510A-61F4-440C-9E04-5E68C9D89FD6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42344252-49CF510A-61F4-440C-9E04-5E68C9D89FD6
Sequencing ALK inhibitors: alectinib in crizotinib-resistant patients, a phase 2 trial by Shaw et al.
P921
Q42344252-49CF510A-61F4-440C-9E04-5E68C9D89FD6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42344252-49CF510A-61F4-440C-9E04-5E68C9D89FD6
rank
NormalRank
type
BestRank
Statement
P921
phase II clinical trial